HIV Citation List: November 25 - December 8, 2009
Pubmed citations:
1. Dammarenolic acid, a secodammarane triterpenoid from Aglaia sp. shows potent anti-retroviral activity in vitro. Esimone CO, Eck G, Nworu CS, Hoffmann D, Uberla K, Proksch P. Phytomedicine. 2009 Dec 3. [Epub ahead of print]PMID: 19962871
2. A dimeric high-molecular-weight chymotrypsin inhibitor with antitumor and HIV-1 reverse transcriptase inhibitory activities from seeds of Acacia confusa. Lam SK, Ng TB. Phytomedicine. 2009 Dec 2. [Epub ahead of print]PMID: 19962287
3. HIV-1 Protease Inhibitors with a Transition-State Mimic Comprising a Tertiary Alcohol: Improved Antiviral Activity in Cells.Mahalingam AK, Axelsson L, Ekegren JK, Wannberg J, Kihlström J, Unge T, Wallberg H, Samuelsson B, Larhed M, Hallberg A. J Med Chem. 2009 Dec 4. [Epub ahead of print]PMID: 19961222
4. A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication.Massari S, Daelemans D, Barreca ML, Knezevich A, Sabatini S, Cecchetti V, Marcello A, Pannecouque C, Tabarrini O. J Med Chem. 2009 Dec 3. [Epub ahead of print]PMID: 19958026
5. A novel lectin with highly potent antiproliferative and HIV-1 reverse transcriptase inhibitory activities from cicada (Cicada flammata). Ye XJ, Ng TB. Appl Microbiol Biotechnol. 2009 Dec 3. [Epub ahead of print]PMID: 19956941
6. Novel galactonic acid-binding hexameric lectin from Hibiscus mutabilis seeds with antiproliferative and potent HIV-1 reverse transcriptase inhibitory activities. Lam SK, Ng TB. Acta Biochim Pol. 2009 Dec 3. [Epub ahead of print]PMID: 19956805
7. A General Approach to Chiral Building Blocks via Direct Amino Acid-Catalyzed Cascade Three-Component Reductive Alkylations: Formal Total Synthesis of HIV-1 Protease Inhibitors, Antibiotic Agglomerins, Brefeldin A, and (R)-gamma-Hexanolide. Ramachary DB, Vijayendar Reddy Y. J Org Chem. 2009 Dec 2. [Epub ahead of print]PMID: 19954143
8. BLOCKADE OF X4 TROPIC HIV-1 CELLULAR ENTRY BY GSK812397, A POTENT NON-COMPETITIVE CXCR4 RECEPTOR ANTAGONIST.Jenkinson S, Thomson M, McCoy D, Edelstein M, Danehower S, Lawrence W, Wheelan P, Spaltenstein A, Gudmundsson K. Antimicrob Agents Chemother. 2009 Nov 30. [Epub ahead of print]PMID: 19949058
9. In vitro synergistic activity against CCR5-tropic HIV-1 with combinations of potential candidate microbicide molecules HHA, KRV2110 and enfuvirtide (T20). Jenabian MA, Saïdi H, Charpentier C, Van Herrewege Y, Son JC, Schols D, Balzarini J, Vanham G, Bélec L; ANRS Multi-Micro Project Study Group. J Antimicrob Chemother. 2009 Dec;64(6):1192-5. Epub 2009 Oct 29.PMID: 19875507
10. Design of HIV protease inhibitors based on inorganic polyhedral metallacarboranes. Rezácová P, Pokorná J, Brynda J, Kozísek M, Cígler P, Lepsík M, Fanfrlík J, Rezác J, Grantz Sasková K, Sieglová I, Plesek J, Sícha V, Grüner B, Oberwinkler H, Sedlácek' J, Kräusslich HG, Hobza P, Král V, Konvalinka J. J Med Chem. 2009 Nov 26;52(22):7132-41.PMID: 19874035
11. Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses. Valiaeva N, Prichard MN, Buller RM, Beadle JR, Hartline CB, Keith KA, Schriewer J, Trahan J, Hostetler KY. Antiviral Res. 2009 Dec;84(3):254-9. Epub 2009 Oct 1.PMID: 19800369
12. Synthesis and anti-HIV-1 integrase activity of modified dinucleotides. Aubert Y, Chassignol M, Roig V, Mbemba G, Weiss J, Meudal H, Mouscadet JF, Asseline U. Eur J Med Chem. 2009 Dec;44(12):5029-44. Epub 2009 Sep 9.PMID: 19796851
13. Synthesis, pharmacological and antiviral activity of 1,3-thiazepine derivatives. Struga M, Kossakowski J, Koziol AE, Kedzierska E, Fidecka S, La Colla P, Ibba C, Collu G, Sanna G, Secci B, Loddo R. Eur J Med Chem. 2009 Dec;44(12):4960-9. Epub 2009 Sep 6.PMID: 19781821
14. Activity and molecular modeling of a new small molecule active against NNRTI-resistant HIV-1 mutants. Carta A, Pricl S, Piras S, Fermeglia M, La Colla P, Loddo R. Eur J Med Chem. 2009 Dec;44(12):5117-22. Epub 2009 Sep 4.PMID: 19775780
ISI Web of Knowledge citations:
15. Revised Structure of the Alkaloid Drymaritin. Wetzel, I; Allmendinger, L; Bracher, F. JOURNAL OF NATURAL PRODUCTS, 2009; 72(10): 1908-1910.
16. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Floss, DM; Sack, M; Arcalis, E; Stadlmann, J; Quendler, H; Rademacher, T; Stoger, E; Scheller, J; Fischer, R; Conrad, U. PLANT BIOTECHNOLOGY JOURNAL, 2009; 7(9): 899-913.
17. Synthesis of new hetero- and carbocyclic aromatic amides of glycyrrhizic acid as potential anti-HIV agents. Kondratenko, RM; Baltina, LA; Baltina, LA; Plyasunova, OA; Pokrovskii, AG; Tolstikov, GA. PHARMACEUTICAL CHEMISTRY JOURNAL, 2009; 43(7); 383-388.
18. Structural investigation of HIV-1 nonnucleoside reverse transcriptase inhibitors: 2-Aryl-substituted benzimidazoles. Ziolkowska, NE; Michejda, CJ; Bujacz, GD. JOURNAL OF MOLECULAR STRUCTURE, 2009; 937(1-3): 34-38.